Takeda and Dr. Reddy''s Laboratories Enter Into Exclusive Collaboration to Promote and Distribute QDENGA® in India''s Pediatric and Adult Private Market

Collaboration focuses on disease awareness, promotion and distribution of Takeda’s dengue vaccine, across India’s private market for pediatric and adult vaccination, ahead of its anticipated availability in the first half of 2027. Collaboration combines Takeda’s global dengue and vaccine expertise with Dr. Reddy’s extensive healthcare network and commercial reach across India. Hyderabad, Telangana, Mumbai, Maharashtra, India --- Business Wire India Takeda Pharmaceutical Company Limited, through